A Single-site, Single Masked, Prospective Comparison of Three Fluoroquinolone Topical Therapies (Besifloxacin 0.6% or Gatifloxacin 0.5% or Moxifloxacin 0.5%) in the Treatment of Infectious Corneal Ulcers.
Phase of Trial: Phase II
Latest Information Update: 20 Aug 2015
Price : $35 *
At a glance
- Drugs Besifloxacin (Primary) ; Gatifloxacin (Primary) ; Moxifloxacin (Primary)
- Indications Bacterial infections; Corneal ulcer
- Focus Therapeutic Use
- 05 Jun 2014 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov record.
- 02 Sep 2013 New trial record